COVIDNews CEPTON-INATO #3
17 April 2020 -
By Marc-Olivier Bévierre
The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals.
We also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.
CEPTON Strategies news
Here are all the reports and analysis we published along with the press articles about us
CEPTON is the author of many publications in the field of healthcare and pharmaceuticals and our partners are often interviewed by the specialized press.